3.64 USD
0 (0%)
3.64 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 84% to XFOR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.87. This target is 143.79% above the current price.
XFOR was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about XFOR.
In the previous month the buy percentage consensus was at a similar level.
XFOR was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-29 | Stifel | Maintains | Buy -> Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | Stifel | Maintains | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-12 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-17 | Stifel | Maintains | Buy -> Buy |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-10 | B. Riley Securities | Maintains | Buy |
| 2023-03-24 | Oppenheimer | Maintains | Outperform |
| 2023-03-22 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-03-22 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-12-12 | Piper Sandler | Initiate | Overweight |
| 2022-11-30 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-19 | B. Riley Securities | Maintains | Buy |
| 2022-05-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-14 | HC Wainwright & Co. | Maintains | Buy |
X4 PHARMACEUTICALS INC / XFOR FAQ
What is the price target for XFOR stock?
11 analysts have analysed XFOR and the average price target is 8.87 USD. This implies a price increase of 143.79% is expected in the next year compared to the current price of 3.64.
What is the consensus rating for X4 PHARMACEUTICALS INC (XFOR) stock?
The consensus rating for X4 PHARMACEUTICALS INC (XFOR) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed X4 PHARMACEUTICALS INC (XFOR)?
The number of analysts covering X4 PHARMACEUTICALS INC (XFOR) is 11.